Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

NABR Files Expanded Petition Challenging the Listing of Long-Tailed Macaques by the IUCN

This image opens in the lightbox

News provided by

National Association for Biomedical Research

01 Feb, 2024, 23:26 GMT

Share this article

Share toX

Share this article

Share toX

WASHINGTON, Feb. 2, 2024 /PRNewswire/ -- Working with recognized, independent scientists, the National Association for Biomedical Research (NABR) filed an expanded petition today with the International Union for Conservation of Nature (IUCN) challenging the designation of the long-tailed macaque (Macaca fascicularis) as "endangered" or "vulnerable" under IUCN listing criteria. 

On October 12, 2023, the IUCN Standards and Petitions Committee accepted NABR's initial petition challenging the IUCN's 2022 designation of long-tailed macaques as "endangered." NABR's initial petition, filed with the IUCN on September 11, 2023, concluded that the underlying scientific justification for the Endangered listing is "biased" and "not based upon the best available scientific information."

Prior to July 2022, long-tailed macaques were designated as "vulnerable" by the IUCN. In 2022, the IUCN revised its designation to "endangered" based upon a scientific review published by Hansen et al. (2022).1 The expanded NABR petition now calls for the IUCN to vacate both the "endangered" and "vulnerable" listings until "a new status assessment of M. fascicularis is conducted by truly independent scientists not involved in advocacy roles for the target species."

The expanded NABR petition follows a recent publication in The American Journal of Primatology, a prominent scientific journal, that reviews scientific information used to determine the conservation status of the long-tailed macaque.2 This publication concludes that "none of the published literature cited to support the IUCN listing as Endangered presents any data to support the hypothesized decline, nor does the literature establish that the species is at risk of becoming extinct."

"The NABR scientific review team is pleased that the IUCN Standards and Petitions Committee will now objectively review this matter," stated Dr. Ray Hilborn, a world-renowned scientist and member of NABR's scientific review team. 

"Given the misrepresentation of the data that has occurred in the 2022 and 2020 assessments, we expect that the IUCN Standards and Petitions Committee will agree with our conclusions" added Dr. Hilborn.

The submission of NABR's expanded petition initiates a formal process with the IUCN Standards and Petitions Committee to review available scientific information concerning the species' status under IUCN protocols.

Long-tailed macaques are the most widely used non-rodent species for drug development as well as for drug safety and efficacy testing. They are also extensively used in cancer research, immunology science, regenerative medicine and genetic disease research.

Long-tailed macaques are considered as an invasive species in many countries including Hong Kong3, Indonesia4,5, Mauritius6, Papua New Guinea,7 and Thailand8. For decades, Asian and African countries have bred specific pathogen free long tailed macaques and exported them to the United States and other countries for biomedical research in laboratories. 

"The NABR petition and 2023 article published in The American Journal of Primatology demonstrate that long-tailed macaques are neither endangered nor vulnerable, but rather a highly invasive species that thrives in the majority of countries where they live," stated Matthew R. Bailey, president of the National Association for Biomedical Research.

"We call upon the IUCN Standards and Petitions Committee to vacate the improper listing of this species as either endangered or vulnerable and undertake a new status assessment of this species by independent scientists."

More information regarding the NABR petition is available online at www.nabr.org. 

About the National Association for Biomedical Research
Founded in 1979, the National Association for Biomedical Research (NABR) is the only 501(c)(6) nonprofit association dedicated to sound public policy for the humane use of animals in biomedical research, education, and testing. Members include more than 340 universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology companies, patient groups, and academic and professional societies who rely on humane and responsible animal research to advance global human and animal health. Learn more about us at www.nabr.org.

1 See Hansen, M. F., Ang, A., Trinh, T. T. H., Sy, E., Paramasivam, S., Ahmed, T., Dimalibot, J., Jones–Engel, L., Ruppert, N., Griffioen, C., Lwin, N.,Phiapalath, P., Gray, R., Kite, S., Doak, N., Nijman, V., Fuentes, A., & Gumert, M. D. (2022). Macaca fascicularis (amended version of 2022 assessment). The IUCN Red List of Threatened Species 2022. https://www.iucn.org/resources/conservation-tool/iucn-red-list-threatened-species

2 See Hilborn, R., & Smith, D. R. (2023). Is the long–tailed macaque at risk of extinction? American Journal of Primatology, e23590. https://doi.org/10.1002/ajp.23590

3 https://www.afcd.gov.hk/english/conservation/con_fau/con_fau_mon/con_fau_mon_wild/con_fau_mon_wild.html

4 https://cites.org/sites/default/files/ndf_material/NDF_MEP_Indonesia_2023%20%281%29.pdf

5 https://www.researchgate.net/publication/346803479_Human_and_long-tailed_macaque_conflict_in_Central_Java_Indonesia 

6 https://link.springer.com/article/10.1007/s10764-022-00324-9

7 http://www.indopacific.org/wp-content/uploads/2017/02/papuamacaques-English-Version.pdf

8 https://www.thainationalparks.com/species/crab-eating-macaque

Logo - https://mma.prnewswire.com/media/1138543/4526597/NABR_Logo.jpg

Modal title

Also from this source

NABR Applauds CITES Standing Committee's Decision Not to Enact Trade Suspension on Cambodia's Long-Tailed Macaques

NABR Applauds CITES Standing Committee's Decision Not to Enact Trade Suspension on Cambodia's Long-Tailed Macaques

The National Association for Biomedical Research (NABR) commends the CITES Standing Committee's decision not to enact a trade suspension on...

The U.S. Fish and Wildlife Service Rejects Petition to List Long-Tailed Macaques Under the Endangered Species Act

The U.S. Fish and Wildlife Service Rejects Petition to List Long-Tailed Macaques Under the Endangered Species Act

On October 7, 2024, the U.S. Fish and Wildlife Service ("USFWS" or "the Service") declined to accept a petition filed by People for the Ethical...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.